In this Review:
Can a peer-group intervention lower CV risk?
QOL impact of post-PCI ranolazine
Individualising post-PCI treatment duration for DAPT
In-hospital initiation of varenicline for ACS patients
Can knowing genetic risk alter LDL cholesterol levels?
Suspected ACS with no flow-limiting coronary artery lesions
Fibrinolytic therapy in STEMI
Multi-vessel intervention in STEMI
Meta-analysis: multi-vessel PCI in STEMI
Multi-vessel vs single vessel PCI during index hospitalisation
Stenosis of non-culprit lesions during primary PCI
Please login below to download this issue (PDF)